Quintiles, Inc. (QTRN) Backs Change to Marketing Mix as NHS Reforms Take Hold  
6/12/2012 10:26:51 AM

READING, United Kingdom--(BUSINESS WIRE)--Quintiles has released the first in a series of briefing papers looking at how market access strategies can help biopharma navigate the risk of commercialising their drugs in the context of healthcare reform across Europe.